Stocklytics Platform
Asset logo for symbol CVS
CVS Health
CVS66
$57.75arrow_drop_down0.55%-$0.32
S&P500
Asset logo for symbol CVS
CVS66

$57.75

arrow_drop_down0.55%
Key Stats
Open$59.50
Prev. Close$59.30
EPS5.62
Next Earnings DateNov 1, 2024
LOWHIGH
Day Range57.40
59.62
52 Week Range52.77
83.25
Ratios
Revenue-
EPS5.62
Fundamentals
Gross Profit-
Industry average yield2.87%
Last Dividend pay dateAug 1, 2024

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

CVSarrow_drop_down2.11%
US Healthcare Sectorarrow_drop_down0.54%
US Marketarrow_drop_down2.10%
warning

CVS / Market

CVS matched the US Market which returned -2.10% over the last twenty four hours.
warning

CVS / Healthcare Sector

CVS lose to the US Healthcare sector which returned -0.54% over the last twenty four hours.

CVS Health (CVS) Statistics

CVS Health Corp (CVS) is a leading healthcare company that operates a chain of pharmacies and retail clinics in the United States. The company was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS is listed on the New York Stock Exchange under the ticker symbol CVS. As of [current date], CVS has a market capitalization of [market cap] and a [valuation metric value] valuation metric.
When it comes to the fundamentals, CVS has shown strong financial performance. The company has recorded [revenue per share] revenue per share, which indicates its ability to generate revenue efficiently. In terms of profitability, CVS has an impressive [profit margin] profit margin, demonstrating its ability to generate profits from its operations. Additionally, CVS has managed its debt well, with a total debt of [total debt] and a low [enterprise to EBITDA] enterprise to EBITDA ratio.
add CVS Health to watchlist

Keep an eye on CVS Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has CVS Health (CVS) stock's performance compared to its sector and the market over the past year?

Over the past year, CVS Health (CVS) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.97%, CVS Health has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 58.78%, it has fallen short of the market average. This comparison highlights CVS Health's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of CVS Health (CVS) stock?

The PE (Price to Earnings) ratio of CVS Health (CVS) is currently 10.33. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of CVS Health (CVS) stock?

The Earnings Per Share (EPS) for CVS Health (CVS), calculated on a diluted basis, is $5.59. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of CVS Health (CVS) stock?

The operating margin for CVS Health (CVS) is 3.03%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of CVS Health (CVS) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of CVS Health (CVS) is $17.03B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does CVS Health (CVS) have?

CVS Health (CVS) has a total debt of $83.82B. The net debt, which accounts for cash and cash equivalents against the total debt, is $71.26B.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media